Charleston, SC -- (SBWIRE) -- 09/05/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: AMR Corporation (OTCMKTS:AAMRQ), mLight Tech, Inc. (OTCMKTS:MLGT), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Imageware Systems Inc (OTCMKTS:IWSY)
AMR Corporation (OTCMKTS:AAMRQ) opened at the price of $3.47 along with 335.53 million shares outstanding and touched its highest price of the day at $3.48 recently, the stock is trading at the price of $3.40 by scoring -1.45 % at time 10:09AM.
The stock’s previous performance of one month showed that it lost almost -43.83%. In previous 3 months it dropped -28.88%. During its current trading session stocks gained a volume of 1.41 million shares up-till now which is lower than its average volume of 14.39 million shares. AMR Corporation operates in the airline industry. The company, through its subsidiary, American Airlines, Inc., provides scheduled jet service to approximately 160 destinations throughout North America, the Caribbean, Latin America, Europe, and Asia.
Has AAMRQ Found The Bottom And Ready To Gain Momentum? Find Out Here
mLight Tech, Inc. (OTCMKTS:MLGT) stock recently hit highest price at $0.38, starting its day trade with a price of $0.33 and reported a decrease of -50.00%, its most recent trading price was $0.160 at 10:10 AM. 52 week price range of the company is $0.14 - $0.38 while today till 10:10AM its minimum price was $0.14. mLight Tech recently added a volume of 2.06 million shares versus its average volume of 46,783 shares.
mLight Tech, Inc., a development stage company, intends to provide software solutions to simplify the management of networked personal computers. It plans to develop products to automate network inventory and reporting, diagramming and documentation, problem identification and resolution, and the assessment of information technology compliance.
Why Should Investors Buy MLGT After the Recent Fall? Just Go Here and Find Out
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) remained among bulls of the day during early hours of trading, as it went up +7.64% recently. Beta value of the stock remained at 10.14 points while its earning per share was -$0.42.
During last 5 day’s it lost -43.29%, while its last one month’s performance stands at -59.86%. The company’s traded volume is 410,182 shares as compares to its average volume of 1.17 million shares. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
For How Long NVIV will Fight for Profitability? Read This Trend Analysis report
Imageware Systems Inc (OTCMKTS:IWSY) is trading with a fall of -11.87% along with the exchange price of $1.93 up till now while its today’s introductory price for today was $2.18.
Company’s 6 month’s performance gave a bright outlook as it gained +103.16% while in its last 5 days its performance remained red with the plummet of -13.06%. Today till 10:14AM its minimum price was $1.76. Imageware Systems recently added a volume of 353,719 shares versus its average volume of 399,118 shares. ImageWare Systems, Inc. provides biometrically enabled software-based identity management solutions for biometrics, secure credential, and law enforcement and public safety markets.
Will IWSY Get Buyers Even After The Recent Rally? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)